သဲစး ဒီး တၢ်ဖီၣ်ဂၢၢ်တၢ်သိၣ်တၢ်သီ
Notice-of-Privacy-Practices-F7676R15.pdf
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 2201 - 2210 လၢ 4139 အစၢတဖၣ်အကျါ
တၢ်ဟ့ၣ်အဘူးအလဲဒီး တၢ်ဃ့အဘူးအလဲ
Employer fully insured group and Medicare group electronic funds transfer form
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP81-21 Save the Date: Best Practices in Value-Based Arrangements
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအီးကထိဘၢၣ် 27, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP82-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Accrufer™ (ferric maltol)
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအီးကထိဘၢၣ် 27, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP83-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Kerendia®
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအီးကထိဘၢၣ် 27, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP84-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Cholestasis Pruritis
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအီးကထိဘၢၣ် 27, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP85R1-21 Resolution Process for Providers Serving Minnesota Health Care Programs (MHCP) Members
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 11, 2022
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
BC-COM-PharmProgPolicyNotifctn-Eff-12-1-21.pdf
တၢ်ဆဲးလီၤမံၤ ဒီးတၢ်ကြၢးဘၣ်ဒီးတၢ်ဃုထၢ
Pay-It Easy Automatic Premium Payment Program Enrollment Form
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP76-21 Commercial and MHCP Pharmacy Benefit Exclusion for Uptravi®
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအီးကထိဘၢၣ် 13, 2021